This Fund Jumped 1,200% on AI Hype, Caution Warned
A private AI-focused fund has surged 1,200% on hype around Anthropic and SpaceX, drawing investor demand but also gro...
Ways To Avoid Falling Into Budget Traps
Discover practical ways to avoid falling into budget traps through smart checks that reinforce your plan and improve long-term financial health.
27,485 articlesFlotek (FTK) 2025 Earnings: Key Takeaways for Investors
As Flotek prepares for its Q3 2025 earnings, investors will parse management tone, margins, and guidance. This articl...
Intel Just Ripped 116% in a Month: Is May a Sell Signal?
Intel has surged 116% in the past month as AI demand strengthens data-center demand and early talks of a potential Ap...
QuantumScape Climbs Eagle Line Milestone
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
Pi Network Drops Update That Changes Creators' Equation
Pi Network announces a major creator-focused update that blends AI with human input, enabling non-technical users to ...
Former Ohio State Athletic Gene Smith Joins M/I Homes Board
Gene Smith, the former Ohio State athletic director, has been elected to M/I Homes’ board of directors. The move come...
Shares Brady Corporation Soaring: Why This Week's Rally Matters
Brady Corporation has captured market attention with a rapid rally. Learn what’s driving shares brady corporation soa...
Live: Will Salesforce’s Earnings Spark a Rebound in Stocks
Salesforce is set to release Q1 results as investors look for evidence that its AI strategy can rekindle growth. A re...
SpaceX Rocket Lab: Which Space Stock Has Room to Run
Investors often ask spacex rocket lab: which has more upside. This in-depth guide compares the private powerhouse Spa...
Alphabet Anthropic's Partnership Could Boost AI Investing Today
A growing alliance between Alphabet and Anthropic could redefine how AI is trained and deployed. This piece breaks do...
Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Could IQIYI Stock Double by 2027? The AI Turnaround Tale
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status